Simplex Trading’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,800
| Closed | -$615K | – | 9083 |
|
|
2025
Q2 | $615K | Sell |
4,800
-5,500
| -53% | -$571K | ﹤0.01% | 3286 |
|
|
2025
Q1 | $911K | Sell |
10,300
-15,900
| -61% | -$1.55M | ﹤0.01% | 2790 |
|
|
2024
Q4 | $2.29M | Sell |
26,200
-3,100
| -11% | -$284K | ﹤0.01% | 2076 |
|
|
2024
Q3 | $2.71M | Sell |
29,300
-3,600
| -11% | -$358K | ﹤0.01% | 2006 |
|
|
2024
Q2 | $3.54M | Buy |
32,900
+21,900
| +199% | +$2.19M | ﹤0.01% | 1685 |
|
|
2024
Q1 | $1.04M | Sell |
11,000
-2,000
| -15% | -$172K | ﹤0.01% | 3071 |
|
|
2023
Q4 | $1.2M | Sell |
13,000
-1,500
| -10% | -$97.2K | ﹤0.01% | 2840 |
|
|
2023
Q3 | $728K | Buy |
14,500
+11,500
| +383% | +$615K | ﹤0.01% | 3003 |
|
|
2023
Q2 | $189K | Sell |
3,000
-29,500
| -91% | -$1.6M | ﹤0.01% | 4350 |
|
|
2023
Q1 | $1.46M | Buy |
32,500
+14,900
| +85% | +$671K | ﹤0.01% | 2222 |
|
|
2022
Q4 | $771K | Sell |
17,600
-14,400
| -45% | -$691K | ﹤0.01% | 2724 |
|
|
2022
Q3 | $2.11M | Buy |
32,000
+9,900
| +45% | +$636K | ﹤0.01% | 1911 |
|
|
2022
Q2 | $1.12M | Buy |
22,100
+21,300
| +2,663% | +$1.25M | ﹤0.01% | 2498 |
|
|
2022
Q1 | $51K | Sell |
800
-13,400
| -94% | -$962K | ﹤0.01% | 7090 |
|
|
2021
Q4 | $1.52M | Buy |
14,200
+13,100
| +1,191% | +$1.37M | ﹤0.01% | 2339 |
|
|
2021
Q3 | $96K | Hold |
1,100
| – | – | ﹤0.01% | 6661 |
|
|
2021
Q2 | $96K | Buy |
1,100
+1,085
| +7,233% | +$99.4K | ﹤0.01% | 6777 |
|
|
2021
Q1 | $145K | Buy |
+15
| New | +$1.5K | ﹤0.01% | 5226 |
|
|
2020
Q2 | – | Sell |
-212
| Closed | -$1.24M | – | 7619 |
|
|
2020
Q1 | $1.24M | Sell |
212
-172
| -45% | -$11.1K | ﹤0.01% | 1686 |
|
|
2019
Q4 | $3.08M | Buy |
384
+220
| +134% | +$16.5K | 0.01% | 1132 |
|
|
2019
Q3 | $1.2M | Sell |
164
-157
| -49% | -$13.6K | ﹤0.01% | 1767 |
|
|
2019
Q2 | $3.03M | Buy |
321
+206
| +179% | +$17K | 0.01% | 1006 |
|
|
2019
Q1 | $920K | Buy |
115
+9
| +8% | +$665 | ﹤0.01% | 2067 |
|
|
2018
Q4 | $571K | Buy |
106
+22
| +26% | +$1.34K | ﹤0.01% | 2099 |
|
|
2018
Q3 | $655K | Sell |
84
-76
| -48% | -$5.28K | ﹤0.01% | 2329 |
|
|
2018
Q2 | $1.01M | Buy |
160
+100
| +167% | +$7.96K | ﹤0.01% | 1779 |
|
|
2018
Q1 | $61K | Buy |
60
+23
| +62% | +$1.98K | ﹤0.01% | 2231 |
|
|
2017
Q4 | $43K | Buy |
37
+7
| +23% | +$493 | ﹤0.01% | 2591 |
|
|
2017
Q3 | $63K | Buy |
30
+1
| +3% | +$53 | ﹤0.01% | 2083 |
|
|
2017
Q2 | $22K | Sell |
29
-48
| -62% | -$2.04K | ﹤0.01% | 3200 |
|
|
2017
Q1 | $26K | Buy |
+77
| New | +$2.76K | ﹤0.01% | 2982 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | -$1K | – | 5848 |
|
|
2016
Q3 | $1K | Buy |
3
+1
| +50% | +$25 | ﹤0.01% | 5249 |
|
|
2016
Q2 | $1K | Buy |
+2
| New | +$36 | ﹤0.01% | 5221 |
|
Other funds holding BPMC
IA
HNB
Simplex Trading's BPMC Position: Q3 2025 in Review
Simplex Trading sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 55,989 shares — an estimated $7.18M sold.
Simplex Trading first reported a position in BPMC in Q3 2015 and held it in 21 quarters. The position peaked at $7.18M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Simplex Trading reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 55,989 Blueprint Medicines shares in Q3 2025, an estimated $7.18M.
- Simplex Trading first reported a position in Blueprint Medicines in Q3 2015 and held it in 21 quarters.
- Simplex Trading's Blueprint Medicines position peaked at $7.18M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.